|Articles|May 1, 2003
MAL-PDT Tx of BCC
Author(s)Barbara J. Rutledge, PhD
San Francisco - Photodynamic therapy (PDT) using methyl aminolevulinate (MAL) as a photosensitizer is as safe and effective as cryotherapy for treatment of primary superficial basal cell carcinoma (sBCC), according to Nicole Basset-Seguin, M.D., professor of dermatology, H~4al Saint-Louis, Paris.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
3
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
4
Dermatology Conferences and Meetings Calendar: December 2025
5














